TABLE I.
Dose | Intravenous | Subcutaneous | |||
---|---|---|---|---|---|
|
|
||||
Early BCa | Metastatic BCa 3-Weekly | Early BCa 3-Weekly | Metastatic BCa 3-Weekly | ||
| |||||
Weekly | 3-Weekly | ||||
Loading | 4 mg/kg over 90 min | 8 mg/kg over 90 min | 8 mg/kg over 90 min | None | None |
| |||||
Maintenance | |||||
First | 2 mg/kg over 90 min | 6 mg/kg over 90 min | 6 mg/kg over 90 min | 600 mg over 2–5 min given in the thigh (alternating left and right) | |
Subsequent | 2 mg/kg over 30 min | 6 mg/kg over 30 min | 6 mg/kg over 30 min |
Adapted from European Medicines Agency, 201010.